Emicizumab utilization, safety, and outcomes in people with severe hemophilia and no inhibitors: 3-year follow-up. A report from the UK Haemophilia Centre Doctors' Organisation.
Journal article
Wall, Caroline, Xiang, Hua, Palmer, Ben, Chowdary, Pratima, Collins, Peter W, Gorman, Richard, Matthias, Mary, Percy, Charles, Sartain, Paul, Shapiro, Susan, Stephensen, David, Talks, Kate and Hay, Charles R M 2025. Emicizumab utilization, safety, and outcomes in people with severe hemophilia and no inhibitors: 3-year follow-up. A report from the UK Haemophilia Centre Doctors' Organisation. Research and Practice in Thrombosis and Haemostasis. 9 (6), p. 103164. https://doi.org/10.1016/j.rpth.2025.103164
| Authors | Wall, Caroline, Xiang, Hua, Palmer, Ben, Chowdary, Pratima, Collins, Peter W, Gorman, Richard, Matthias, Mary, Percy, Charles, Sartain, Paul, Shapiro, Susan, Stephensen, David, Talks, Kate and Hay, Charles R M |
|---|---|
| Abstract | Background Objectives Methods Results Conclusions |
| Keywords | Safety; Efficacy; Hemophilia A; Emicizumab; Non-inhibitor |
| Year | 2025 |
| Journal | Research and Practice in Thrombosis and Haemostasis |
| Journal citation | 9 (6), p. 103164 |
| Publisher | Elsevier |
| ISSN | 2475-0379 |
| Digital Object Identifier (DOI) | https://doi.org/10.1016/j.rpth.2025.103164 |
| Official URL | https://pmc.ncbi.nlm.nih.gov/articles/PMC12494912/pdf/main.pdf |
| Funder | Roche Products Ltd |
| Publication dates | |
| 01 Aug 2025 | |
| Online | 01 Sep 2025 |
| Publication process dates | |
| Accepted | 28 Jul 2025 |
| Deposited | 15 Oct 2025 |
| Publisher's version | License File Access Level Open |
| Output status | Published |
https://repository.canterbury.ac.uk/item/9w4zq/emicizumab-utilization-safety-and-outcomes-in-people-with-severe-hemophilia-and-no-inhibitors-3-year-follow-up-a-report-from-the-uk-haemophilia-centre-doctors-organisation
Download files
22
total views8
total downloads8
views this month1
downloads this month